DCM/Lev Fin - need help

Hi Monkeys,

This may seem like a stupid question, and most likely is a stupid question. Anyway, here goes.

As far as my understanding the Lev Fin product group provide HY bonds, leverage loans (for sponsors and strategic M&A), mezz etc - while the DCM group provide lower risk debt products like IG bonds.

  1. Does DCM also provide loans? (hence Lev Fin and DCM both provide several types of debt but the difference is lower vs higher risk)

I believe all IBs have better/worse connection with ret/inst investors in regards to bonds, but some banks simply do not have a retail/commercial bank backing them and therefore must source loans through other banks. I would assume the banks providing loan capital are in a much better position of winning these mandates and therefore outcompete the "non-balance sheet" players.

2a) How can an IB be a top tier DCM/Lev Fin player without having a "balance sheet"?

2b) Are the sourcing of the capital just a "trivial" part in grand scheme of providing leverage loans - and IBs therefore demonstrates their value add through other advice and expertise?

7 Comments
 
Most Helpful

2a: Having a balance sheet definitely helps. Debt issuers will often want their lead bank to hold a large position of their debt. But, you also compete on pricing, more aggressive leverage, or allowing for more aggressive/issuer-friendly credit terms. Banks will provide commitment letters (which are legally binding) so if you can provide more favorable pricing/structure/terms than other banks without getting hung on syndication, you're in a better position to win the mandate. The flip side is you better be pretty damn confident that you can execute and sell to debt investors what you agree to in your commitment letters or you'll find yourself out of a job very quickly.

2b: Not trivial because of reason I previously mentioned (you gotta pay-to-play), but not exactly as critical because levfin is typically a flow business and you can de-risk your exposure in a relatively short period of time. Yes, you need enough balance sheet to make the initial commitment, but if you can sell the paper very quickly, having a massive balance sheet isn't as important (for example, Jefferies and Nomura have relatively small balance sheets).

 

Consequatur quasi voluptatem natus aut molestiae et laudantium aperiam. Libero ducimus unde voluptatem magni enim velit.

Atque modi nobis ipsam praesentium ullam exercitationem aut. Tempora magni velit repellendus reprehenderit ea ipsa. Eaque quam nesciunt eos harum dolorem beatae necessitatibus aliquid. Voluptate ad soluta amet ut necessitatibus eveniet.

Fugiat aut corporis et. Occaecati hic doloribus nesciunt ullam perferendis.

Et sint animi soluta eum vel sequi veniam asperiores. Repellendus et sunt vitae ea recusandae aut qui. Est et velit tempora ut veritatis ex quo iste.

Career Advancement Opportunities

September 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Goldman Sachs 01 97.8%
  • Morgan Stanley 07 97.3%

Overall Employee Satisfaction

September 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.4%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

September 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 07 98.4%
  • Goldman Sachs 01 97.8%
  • JPMorgan No 97.3%

Total Avg Compensation

September 2026 Investment Banking

  • Vice President (16) $429
  • Associates (51) $260
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (26) $182
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”